LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

Search

Dr Reddy's Laboratories Ltd-ADR

Closed

SectorHealthcare

15.32 -0.97

Overview

Share price change

24h

Current

Min

15.26

Max

15.52

Key metrics

By Trading Economics

Income

1.8B

16B

Sales

1.5B

85B

P/E

Sector Avg

19.628

50.291

EPS

19.11

Dividend yield

0.62

Profit margin

18.66

Employees

27,811

EBITDA

985M

25B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+9.03% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.62%

2.40%

Market Stats

By TradingEconomics

Market Cap

10B

13B

Previous open

16.29

Previous close

15.32

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Dr Reddy's Laboratories Ltd-ADR Chart

Past performance is not a reliable indicator of future results.

Related News

9 May 2025, 18:56 UTC

Earnings

Dr Reddy's Laboratories 4Q EPS INR19.11 >RDY

9 May 2025, 18:56 UTC

Earnings

Dr Reddy's Laboratories 4Q Rev INR85.06B >RDY

23 Jan 2025, 17:46 UTC

Earnings

Dr. Reddy's 3Q Net Attributable to Equity Holders of Parent Company INR14.13B

23 Jan 2025, 17:42 UTC

Earnings

Dr. Reddy's 3Q Rev INR83.59B

5 Nov 2024, 11:01 UTC

Earnings

Dr. Reddy's Laboratories 1H Rev INR156.89B Vs. INR136.19B >RDY

5 Nov 2024, 11:00 UTC

Earnings

Dr. Reddy's Laboratories 1H Net INR26.47B Vs. Net INR28.825B >RDY

5 Nov 2024, 10:57 UTC

Earnings

Dr. Reddy's Laboratories 2Q Net INR12.55B Vs. Net INR14.80B >RDY

5 Nov 2024, 10:57 UTC

Earnings

Dr. Reddy's Laboratories 2Q Rev INR80.16B Vs. INR68.80B >RDY

Peer Comparison

Price change

Dr Reddy's Laboratories Ltd-ADR Forecast

Price Target

By TipRanks

9.03% upside

12 Months Forecast

Average 16.9 USD  9.03%

High 16.9 USD

Low 16.9 USD

Based on 1 Wall Street analysts offering 12 month price targets forDr Reddy's Laboratories Ltd-ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

N/A / 13.84Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Dr Reddy's Laboratories Ltd-ADR

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.